doi:10.1007/s12250-016-3742-4

Assiri, McGeer, Perl, Price, Al Rabeeah, Cummings, Alabdullatif, Assad, Almulhim, Makhdoom, Madani, Alhakeem, Al-Tawfiq, Cotton, Watson, Kellam, Zumla, Memish, KSA MERS-CoV Investigation Team, 2013: Hospital outbreak of Middle East respiratory syndrome coronavirus[J]. N Engl J Med, 369, 407-416. doi: 10.1056/NEJMoa1306742
Baez-Santos YM, Barraza SJ, Wilson MW, Agius MP, Mielech AM, Davis NM, Baker SC, Larsen SD, Mesecar AD, 2014a: X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases[J]. J Med Chem, 57, 2393-2412. doi: 10.1021/jm401712t
Baez-Santos YM, Mielech AM, Deng X, Baker S, Mesecar AD, 2014b: Catalytic function and substrate specificity of the PLpro domain of nsp3 from the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)[J]. J Virol, 88, 12511-12527. doi: 10.1128/JVI.01294-14
Bailey-Elkin BA, Knaap RC, Johnson GG, Dalebout TJ, Ninaber DK, van Kasteren PB, Bredenbeek PJ, Snijder EJ, Kikkert M, Mark BL, 2014: Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression[J]. J Biol Chem, 289, 34667-34682. doi: 10.1074/jbc.M114.609644
Barretto N, Jukneliene D, Ratia K, Chen Z, Mesecar AD, Baker SC, 2005: The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity[J]. J Virol, 79, 15189-15198. doi: 10.1128/JVI.79.24.15189-15198.2005
Bekes M, Rut W, Kasperkiewicz P, Mulder MP, Ovaa H, Drag M, Lima CD, Huang TT, 2015: SARS hCoV papain-like protease is a unique Lys⁴⁸ linkage-specific di-distributive deubiquitinating enzyme[J]. Biochem J, 468, 215-226. doi: 10.1042/BJ20141170
Butler D, 2015: South Korean MERS outbreak spotlights lack of research[J]. Nature, 522, 139-140. doi: 10.1038/522139a
Chang CK, Hou MH, Chang CF, Hsiao CD, Huang TH, 2014: The SARS coronavirus nucleocapsid protein-forms and functions[J]. Antiviral Res, 103, 39-50. doi: 10.1016/j.antiviral.2013.12.009
Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC, 2010: MolProbity: all-atom structure validation for macromolecular crystallography[J]. Acta Crystallogr D Biol Crystallogr, 66, 12-21. doi: 10.1107/S0907444909042073
Chen Y, Cai H, Pan J, Xiang N, Tien P, Ahola T, Guo D, 2009: Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase[J]. Proc Natl Acad Sci USA, 106, 3484-3489. doi: 10.1073/pnas.0808790106
Chou CY, Lai HY, Chen HY, Cheng SC, Cheng KW, Chou YW, 2014: Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease[J]. Acta Crystallogr D Biol Crystallogr, 70, 572-581.
Dikic I, Wakatsuki S, Walters KJ, 2009: Ubiquitin-binding domains-from structures to functions[J]. Nat Rev Mol Cell Biol, 10, 659-671.
Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Müller S, Rickerts V, Stürmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW, 2003: Identification of a novel coronavirus in patients with severe acute respiratory syndrome[J]. N Engl J Med, 348, 1967-1976. doi: 10.1056/NEJMoa030747
Eckerle I, Müller MA, Kallies S, Gotthardt DN, Drosten C, 2013: In-vitro renal epithelial cell infection reveals a viral kidney tro-pism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) coronavirus infection[J]. Virol J, 10, 359-. doi: 10.1186/1743-422X-10-359
Emsley P, Lohkamp B, Scott WG, Cowtan K, 2010: Features and development of Coot[J]. Acta Crystallogr D Biol Crystallogr, 66, 486-501. doi: 10.1107/S0907444910007493
Fetics SK, Guterres H, Kearney BM, Buhrman G, Ma B, Nussinov R, Mattos C, 2015: Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD[J]. Structure, 23, 505-516. doi: 10.1016/j.str.2014.12.017
Frieman M, Ratia K, Johnston RE, Mesecar AD, Baric RS, 2009: Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antago-nism of IRF3 and NF-κB signaling[J]. J Virol, 83, 6689-6705. doi: 10.1128/JVI.02220-08
Hale BG, Randall RE, Ortin J, Jackson D, 2008: The multifunctional NS1 protein of influenza A viruses[J]. J Gen Virol, 89, 2359-2376. doi: 10.1099/vir.0.2008/004606-0
Hamre D, Procknow JJ, 1966: A new virus isolated from the human respiratory tract[J]. Proc Soc Exp Biol Med, 121, 190-193. doi: 10.3181/00379727-121-30734
Harcourt BH, Jukneliene D, Kanjanahaluethai A, Bechill J, Severson KM, Smith CM, Rota PA, Baker SC, 2004: Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity[J]. J Virol, 78, 13600-13612. doi: 10.1128/JVI.78.24.13600-13612.2004
Headd JJ, Echols N, Afonine PV, Grosse-Kunstleve RW, Chen VB, Moriarty NW, Richardson DC, Richardson JS, Adams PD, 2012: Use of knowledge-based restraints in phenix.refine to improve macromolecular refinement at low resolution[J]. Acta Crystallogr D Biol Crystallogr, 68, 381-390. doi: 10.1107/S0907444911047834
Hilgenfeld R, 2014: From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design[J]. FEBS J, 281, 4085-4096. doi: 10.1111/febs.2014.281.issue-18
Hilgenfeld R, Peiris M, 2013: From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses[J]. Antiviral Res, 100, 286-295. doi: 10.1016/j.antiviral.2013.08.015
Hu M, Li P, Song L, Jeffrey PD, Chenova TA, Wilkinson KD, Cohen RE, Shi Y, 2005: Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14[J]. EMBO J, 24, 3747-3756. doi: 10.1038/sj.emboj.7600832
Kabsch W, 2010: XDS[J]. Acta Crystallogr D Biol Crystallogr, 66, 125-132. doi: 10.1107/S0907444909047337
Krissinel E, Henrick K, 2007: Inference of macromolecular assemblies from crystalline state[J]. J Mol Biol, 372, 774-797. doi: 10.1016/j.jmb.2007.05.022
Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ, SARS Working Group, 2003: A novel coronavirus associated with severe acute respira-tory syndrome[J]. N Engl J Med, 348, 1953-1966. doi: 10.1056/NEJMoa030781
Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W, Ling AE, Chan PK, Tam JS, Zambon MC, Gopal R, Drosten C, van der Werf S, Escriou N, Manuguerra JC, Stöhr K, Peiris JS, Osterhaus AD, 2003: Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome[J]. Lancet, 362, 263-270. doi: 10.1016/S0140-6736(03)13967-0
Lee H, Lei H, Santarsiero BD, Gatuz JL, Cao S, Rice AJ, Patel K, Szypulinski MZ, Ojeda I, Ghosh AK, Johnson ME, 2015: Inhibi-tor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV[J]. ACS Chem Biol, 10, 1456-1465. doi: 10.1021/cb500917m
Lei J, Mesters JR, Drosten C, Anemüller S, Ma Q, Hilgenfeld R, 2014: Crystal structure of the papain-like protease of MERS-coronavirus reveals unusual, potentially druggable active-site features[J]. Antiviral Res, 109, 72-82. doi: 10.1016/j.antiviral.2014.06.011
Liu YC, Penninger J, Karin M, 2005: Immunity by ubiquitylation: a reversible process of modification[J]. Nat Rev Immunol, 5, 941-952. doi: 10.1038/nri1731
Maringer K, Fernandez-Sesma A, 2014: Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection[J]. Cytokine Growth Factor Rev, 25, 669-679. doi: 10.1016/j.cytogfr.2014.08.004
McIntosh K, Becker WB, Chanock RM, 1967: Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease[J]. Proc Natl Acad Sci USA, 58, 2268-2273. doi: 10.1073/pnas.58.6.2268
Mielech AM, Kilianski A, Baez-Santos YM, Mesecar AD, Baker SC, 2014: MERS-CoV papain-like protease has delSGylating and deubiquitinating activities[J]. Virology, 450-451, 64-70. doi: 10.1016/j.virol.2013.11.040
Mielech AM, Deng X, Chen Y, Kindler E, Wheeler DL, Mesecar AD, Thiel V, Perlman S, Baker SC, 2015: Murine coronavirus ubiquitin-like domain is important for papain-like protease stability and viral pathogenesis[J]. J Virol, 89, 4907-4917. doi: 10.1128/JVI.00338-15
Mueller U, Darowski N, Fuchs MR, F?rster R, Hellmig M, Paithankar KS, Pühringer S, Steffien M, Zocher G, Weiss MS, 2012: Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin[J]. J Synchrotron Radiat, 19, 442-449. doi: 10.1107/S0909049512006395
Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY, SARS Study Group, 2003: Coronavirus as a possible cause of severe acute respiratory syndrome[J]. Lancet, 361, 1319-1325. doi: 10.1016/S0140-6736(03)13077-2
Pfoh R, Lacdao IK, Georges AA, Capar A, Zheng H, Frappier L, Saridakis V, 2015: Crystal structure of USP7 ubiquitin-like domains with an ICP0 peptide reveals a novel mechanism used by viral and cellular proteins to target USP7[J]. PLoS Pathog, 11, e1004950-. doi: 10.1371/journal.ppat.1004950
Ratia K, Kilianski A, Baez-Santos YM, Baker SC, Mesecar AD, 2014: Structural basis for the ubiquitin-linkage specificity and deISGylating activity of SARS-CoV papain-like protease[J]. PLoS Pathog, 10, e1004113-. doi: 10.1371/journal.ppat.1004113
Vagin A, Teplyakov A, 2010: Molecular replacement with MOLREP[J]. Acta Crystallogr D Biol Crystallogr, 66, 22-25.
van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, Wertheim-van Dillen PM, Kaandorp J, Spaargaren J, Berkhout B, 2004: Identification of a new human coronavirus[J]. Nat Med, 10, 368-373. doi: 10.1038/nm1024
Vijay-Kumar S, Bugg CE, Cook WJ, 1987: Structure of ubiquitin refined at 1.8 Å resolution[J]. J Mol Biol, 194, 531-534. doi: 10.1016/0022-2836(87)90679-6
Wang H, Xue S, Yang H, Chen C, 2016: Recent progress in the discovery of inhibitors targeting coronavirus proteases[J]. Virol Sin, 31, 24-30. doi: 10.1007/s12250-015-3711-3
Weiss MS, Hilgenfeld R, 1997: On the use of the merging R factor as a quality indicator for X-ray data[J]. J Appl Cryst, 30, 203-205. doi: 10.1107/S0021889897003907
Wojdyla JA, Manolaridis I, van Kasteren PB, Kikkert M, Snijder EJ, Gorbalenya AE, Tucker PA, 2010: Papain-like protease 1 from transmissible gastroenteritis virus: crystal structure and enzymatic activity toward viral and cellular substrates[J]. J Virol, 84, 10063-10073. doi: 10.1128/JVI.00898-10
Woo PC, Lau SK, Chu CM, Chan KH, Tsoi HW, Huang Y, Wong BH, Poon RW, Cai JJ, Luk WK, Poon LL, Wong SS, Guan Y, Peiris JS, Yuen KY, 2005: Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia[J]. J Virol, 79, 884-895. doi: 10.1128/JVI.79.2.884-895.2005
Yang X, Chen X, Bian G, Tu J, Xing Y, Wang Y, Chen Z, 2013: Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease[J]. J Gen Virol, 95, 614-626.
Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA, 2012: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J]. N Engl J Med, 367, 1814-1820. doi: 10.1056/NEJMoa1211721